Related Experiment Video
Updated: Jun 24, 2026

A Microbiomechanical System for Studying Varicosity Formation and Recovery in Central Neuron Axons
Published on: April 30, 2018
Brain derived versican V2 is a potent inhibitor of axonal growth
M Schmalfeldt1, C E Bandtlow, M T Dours-Zimmermann
1Molecular Biology Laboratory, Department of Pathology, University of Zurich, Switzerland.
Abstract:
In this paper, we identify the chondroitin sulfate proteoglycan versican V2 as a major inhibitor of axonal growth in the extracellular matrix of the mature central nervous system. In immunohistochemical and in situ hybridization experiments we show that this tissue-specific splice variant of versican is predominantly present in myelinated fiber tracts of the brain and in the optic nerve, most likely being expressed by oligodendrocytes. We demonstrate that isolated versican V2 strongly inhibits neurite outgrowth of central and peripheral neurons in stripe-choice assays using laminin-1 as permissive substrate. The inhibitory character of versican V2 is maintained after removal of chondroitin sulfate and N- and O-linked oligosaccharide side chains, but it is abolished after core protein digestion with proteinase-K. Our data support the notion, that intact versican V2 prevents excessive axonal growth during late phases of development and hereby participates in the structural stabilization of the mature central nervous system.
Related Concept Videos
Neurogenesis and Regeneration of Nervous Tissue
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...

